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Abstract 
Exposure to space radiation may pose a risk to skeletal health during subsequent aging. 
Irradiation acutely stimulates bone remodeling in mice, although the long-term influence of space 
radiation on bone-forming potential (osteoblastogenesis) and possible adaptive mechanisms are 
not well understood. We hypothesized exposure to ionizing radiation impairs osteoblastogenesis 
in an ion-type specific manner, with low doses capable of modulating expression of redox-related 
genes. 16-wk old, male, C57BL6/J mice were exposed to low linear-energy-transfer (LET) protons 
(150 MeV/n) or high-LET 56Fe ions (600 MeV/n) using either low (5 or 10 cGy) or high (50 or 
200 cGy) doses at NASA’s Space Radiation Lab at Brookhaven National Lab (NSRL/BNL). 
Tissues were harvested 5 weeks or 1 year after irradiation and bones were analyzed by 
microcomputed tomography for cancellous microarchitecture and cortical geometry. Marrow-
derived, adherent cells were grown under osteoblastogenic culture conditions. Cell lysates were 
analyzed for select groups by RT-PCR during the proliferative phase or the mineralizing phase, 
and differentiation was analyzed by imaging mineralized nodules (% surface area). Representative 
genes were selected for expression analyses, including cell proliferation (PCNA, Cdk2, p21, p53), 
differentiation (Runx2, Alpl, Bglap), oxidative metabolism (Catalase, GPX, MnSOD, CuZnSOD, 
iNos, Foxo1), DNA-damage repair (Gadd45), or apoptosis (Caspase 3). As expected, a high dose 
(200 cGy), but not low doses, of either 56Fe or protons caused a loss of cancellous bone 
volume/total volume. Marrow cells produced mineralized nodules ex vivo regardless of radiation 
type or dose; 56Fe (200 cGy) inhibited median nodule area by more than 90% at 5 weeks and 1 
year post-irradiation, compared to controls. At 5 weeks post exposure, irradiation with protons or 
56Fe caused few changes in gene expression levels during osteoblastogenesis, although a high dose 
56Fe (200 cGy) increased levels of Catalase and Gadd45. In addition, supplementing cell culture 
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media with SOD protected marrow-derived osteoprogenitors from the damaging effects of 
exposure to low-LET (137Cs gamma) if irradiated in vitro, but had limited protective effects on 
high-LET 56Fe-exposed cells. In sum, exposure of mice to either protons or 56Fe at a relatively 
high dose (200 cGy) caused persistent bone loss, whereas only high-LET 56Fe increased expression 
of redox-related genes and inhibited osteoblastogenesis, albeit to a limited extent. We conclude 
that high-LET irradiation impaired osteoblastogenesis and regulated steady-state gene expression 
of select redox-related genes during osteoblastogenesis, which may contribute to persistent bone 
loss.  
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Introduction  
Structural degradation and oxidative stress following exposure to space radiation 
potentially endangers skeletal health of astronauts, both during the mission and later in life. For 
exploration missions into deep space, galactic cosmic-rays (GCR) are of particular concern 
because of their high-energy and densely ionizing pattern of energy deposition [1,2], which can 
induce oxidative stress [3,4] in various tissues. Both solar particle-emissions (SPE) and GCR 
contribute to the mixed composition of low-energy radiation (such as protons and gamma rays), 
high linear-energy-transfer (LET) particles (such as ionized 56Fe- and 12C-nuclei) and secondary 
constituents such as Bremmstrahlung, fragmentation products, and neutrons [5,6]. 
Irradiation perturbs the redox balance within the bone and marrow compartment in a 
complex and transient manner. Total-body irradiation (137Cs, 200 cGy) induces rapid reactive 
oxidative species formation in the marrow [7] and increases expression of the master transcription 
factor that binds to the antioxidant response element, nuclear factor (erythroid-derived 2)-like 2 
(Nrf2) [8].  Excess reactive oxygen species (ROS) can interfere with osteogenesis by bone marrow 
derived osteoprogenitors [9,10] as well as contribute to bone resorption by osteoclasts [11]. High-
LET 56Fe (≥ 200 cGy) impairs cell proliferation during osteoblastogenesis from marrow 
progenitors in a dose-dependent manner [12]. Further, irradiation in vitro with 56Fe (100 cGy) 
arrests the cell cycle and inhibits proliferation of mesenchymal stem cells [13]. At higher doses (4-
8 Gy), irradiation with x-rays increases ROS, depletes antioxidant stores, increases Nrf2 protein 
levels, and reduces differentiation in osteoblast-like cells [14]. However, the role of oxidative 
stress on the potential for total-body irradiation (TBI) to impair osteoblastogenesis over the long 
term, in particular low-dose, high-LET species, has not been fully characterized. 
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We posed three principal questions to address in this study. First, are the severity of acute 
bone loss [7,8,15,16] and impairment of osteoblastogenesis [12] following TBI dependent on 
radiation type (LET) or dose? Secondly, which pathways are activated? Finally, do irradiation-
induced insults to skeletal structure and osteoblastogenesis persist long after exposure? We 
hypothesized that: 1) irradiation-induced bone loss, shown previously to be dominated by total 
dose of exposure [17], leads to temporal perturbations in antioxidant defenses; 2) TBI induces both 
persistent changes in redox-related genes and cancellous microarchitecture in an ion-dependent 
manner; and 3) addition of an antioxidant, here the enzyme superoxide dismutase (SOD), mitigates 
irradiation-induced damage to osteoprogenitors and stem cells when exposed in vitro, implicating 
an oxidative-stress dependent mechanism. 
We found that there are persistent and profound decrements in mineralized nodules after 
total body irradiation (at 200 cGy) with 56Fe, while protons had a milder effect. In contrast to 
our hypothesis, few changes in steady state expression of redox-related genes during 
osteoblastogenesis ex vivo after total-body irradiation, although there some indication of altered 
expression of select genes during the proliferative phase (at 200 cGy 56Fe). Furthermore, 
scavenging ROS with an antioxidant (i.e., SOD) mitigated adverse effects of in vitro irradiation 
with gamma rays, but failed to protect fully from irradiation with an equivalent dose of heavy 
ions.  
 
Results  
TBI Experiment Design 
To evaluate the individual effects of radiation type, our study queried a dose response to 
high-LET 56Fe or low-LET protons (see Methods below for details) at 1 day, 7 days, or 5 weeks 
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post-exposure. Additionally, we assessed the sequelae of 56Fe irradiation at a late, 1-year post 
exposure endpoint (Figures 1A and 1B). Tibiae and femora were collected for assessment of the 
cancellous microarchitecture. Bone-marrow cells were cultured ex vivo in osteoblastogenic 
media for colony counts and mineralization assays. Additionally, the effects of total body 
irradiation on gene expression were assayed at two points, during the proliferation and 
mineralization phase, of osteoblastogenesis. 
 
Body Mass Temporal Responses and Coat Color 
Body mass was measured ( 0.1 g), at least weekly, throughout the study as an index of 
general health (Figure 2, showing the 1-year post irradiation cohorts). As determined by one-way 
ANOVA and Dunnett’s posthoc, within 6 days of exposure, 56Fe (200 cGy) reduced the cohort’s 
mean body mass by 4% relative to starting weights. Other doses and ions had no significant 
effect relative to starting weights (data not shown).  Shipment of the mice from BNL to NASA 
Ames between days 6 and 8, caused a 5% decline in body weights of all groups.  
Following shipment, body mass of all groups rose over time (+7% for the 5-week 
endpoint and +46% for the 1-year endpoint), with no treatment effect, nor interaction of 
time*treatment (Figure 2). By the time of euthanasia at 5-weeks or 1-year post-irradiation, body 
mass did not significantly differ between irradiated and age-matched sham-controls. 
Additionally, as an index of general health, the coat color was assessed as gray or black at 
the end of the experiment (1-year post-irradiation). In sham controls, 1 out of 13 mice had a gray 
coat. In contrast, 56Fe (200 cGy) caused all of the 11 to have gray coats. The lower doses of 56Fe 
irradiation, 10 or 50 cGy, did not modulate coat color compared to sham-controls, respectively.  
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Bone Structure  
Microcomputed tomography was used to assess the effects of aging and irradiation on the 
cancellous tissue in the proximal tibial metaphysis at the 5 week and 1 year endpoints (Figure 
1A) and cortical geometry of the femoral midshaft at the 1 year endpoint. In sham-treated animal 
cohorts, aging caused a 54% reduction of cancellous bone volume/total volume (BV/TV) 
between the 5-week and 1-year post-treatment endpoints (Fig. 3A and Table 1). 
At 5 weeks post-irradiation, 50 and 200 cGy 56Fe caused a decrement in BV/TV (Fig. 3A, 
-16% and -31%, respectively) and strut number (Tb.N, Fig 3B, -16% and -31%, respectively) in 
the cancellous region of the proximal tibia, compared to shams. For protons, 200 cGy caused a -
22% decrement in BV/TV (Fig. 3A) and Tb.N (Fig 3B), while 50 cGy showed a trend towards 
decreased BV/TV (-11%, p = 0.12) and Tb.N (-13%, p = 0.06). Additionally, irradiation at 200 
cGy increased trabecular separation, but did not affect trabecular thickness (data not shown). At 
5 or 10 cGy, neither 56Fe, nor protons, showed any detectable bone loss, by any structural 
measure.  
At 1 year post-irradiation, 56Fe (200 cGy) showed a trend of decreased BV/TV and Tb.N 
(-25%, p = 0.12, Table 1) in the cancellous region of the proximal tibia, as compared to age-
matched controls. No changes were observed at 10 or 50 cGy doses compared to controls. 
Additionally, no significant changes in cortical geometry of the femur at midshaft (bone volume 
and cortical thickness, data not shown) were detected, compared to age-matched controls. 
 
Ex vivo Osteoblastogenesis 
To assess the cellular responses to irradiation during ex vivo osteoblast growth and 
maturation, we cultured marrow progenitor cells at the 5 week and 1 year post-irradiation 
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endpoints. For cultures plated 5 weeks post-irradiation, gene expression, alkaline phosphatase 
activity, colony counts, and DNA content analyses were performed during the proliferative phase 
(7 days after plating) and mineralization phase (19 to 21 days after plating). At the end of the 
latter phase, the mineralized area was quantified to assess the functional outcome of 
differentiation. 
During the mineralization phase, we observed well-formed nodules in the sham and 
proton-irradiated (200 cGy) groups (Figures 4A-B), with sham values displaying wide variance. 
In contrast, we observed very few, yet fully mineralized, nodules in the 56Fe-irradiated (200 cGy) 
group (Fig 4A-B). After quantifying the nodule area, irradiation with 56Fe (200 cGy) tended to 
cause an -91% decrement (p = 0.06, Fig 4A-B) in the mineralization area (median) compared to 
sham-irradiated controls. This inhibitory effect is consistent with findings from our other 
experiments with this dose of 56Fe at various times after exposure (data not shown). Although, 
mineralization area of cultures from animals exposed to protons (200 cGy) tended to be lower 
than sham-controls (-70%, p = 0.10, Fig 4A-B), nodules from proton-irradiated mice appeared 
larger and more widespread than in cultures from 56Fe-irradiated mice (Fig 4B). Lower doses of 
either species did not affect mineralized area or any other measured parameters (data not shown).  
Radiation exposure did not modify expression levels for most of the genes analyzed 
during the mineralization phase (Table 2), although a high dose of 56Fe (200 cGy) tended to 
decrease expression of the osteoblast differentiation gene Alpl by -60% (p = 0.12), Fig 4C. 
Additionally, a low dose of 56Fe (10 cGy) increased the expression of the antioxidant gene 
CuZnSOD (+90%), compared to sham-controls, whereas proton exposure did not modify 
expression levels for any of the genes assayed (data not shown). Taken together, these data 
suggest mild effects late in culture, but only for 56Fe, not protons. 
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During the proliferative phase, most doses and types of radiation exposure did not modify 
the expression levels for genes analyzed when compared to sham-controls (Table 2). A high-dose 
of 56Fe (200 cGy) did however increase expression levels of genes for the cell cycle arrest 
marker Gadd45 (+223%) and the antioxidant Catalase (+81%) and also tended to increase the 
late-osteoblastic marker Bglap (+196%, p = 0.08) (Fig 4D). A lower dose of 56Fe (5 cGy) 
decreased gene expression of the nitric oxide generator iNOS by -53% and increased Gadd45 by 
+91%, respectively, compared to sham controls. 
 For the ex vivo marrow culture performed 1-year post irradiation, the numbers of colonies 
were counted 8 days after plating and nodule areas were assessed 28 days after plating. 56Fe 
irradiation (200 cGy) reduced colony counts at day 8 (-45%, Fig 5A) compared to controls, 
whereas lower doses of 56Fe (10 and 50 cGy) had no effect (data not shown). At 28 days after 
plating, cells from 56Fe (200 cGy)-irradiated mice tended to show reduced mineralized area (-
96% reduction of median, p < 0.06, Fig 5B), whereas lower doses had no effect (data not shown) 
compared to controls. Taken together, these data suggest that only the highest dose of 56Fe had a 
persistent effect to inhibit osteoblastogenesis, as assessed by colony formation. 
 
Total Antioxidant Capacity of the Marrow Extracellular Fluid 
To assess changes in the redox microenvironment in the marrow cavity following 
irradiation, we measured the antioxidant capacity of the extracellular fluid from the marrow, 
(normalized by protein concentration in the fluid) at 1 and 7 days after exposure to 56Fe or 
protons (Figure 1B). Protons (200 cGy) or 56Fe (200 cGy) decreased the total antioxidant 
capacity of the marrow extracellular fluid by over 35% within one day of exposure (Fig 6). In 
contrast, 7 days after exposure, protons caused a 62% elevation of antioxidant capacity (Figure 
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6) whereas 56Fe did not differ from sham controls. Lower doses of radiation (5 cGy 56Fe or 10 
cGy proton), did not modify antioxidant capacity per proton concentration with sham-controls at 
either timepoint (data not shown).  
 
In Vitro Radiation Effects on Osteoblastogenesis 
We hypothesized that a radiation-induced rise in ROS damages osteoprogenitors, leading 
to a decrease in number and activity of differentiated progeny and therefore exogenous antioxidant 
is expected to mitigate adverse effects of radiation on the proliferation and subsequent 
differentiation of osteoprogenitors derived from the marrow. The influence of a low-LET species 
(137Cs) was compared to that of high-LET 56Fe. Adherent marrow cells grown under 
osteoblastogenic culture conditions were irradiated at day 3 in culture and the % change in DNA 
content between day 3 (day of irradiation) and day 10 calculated as a surrogate of culture growth 
(proliferation).  Analysis of the dose-response to 137Cs and 56Fe revealed significant decrements in 
growth after exposure to 137Cs (200 cGy and 500 cGy) or 56Fe (100 cGy, 200 cGy), but not after 
exposure to lower doses (Fig 7A). Colony counts also were affected at the higher doses of radiation 
(data not shown). In summary, as shown in Fig. 7A, osteoprogenitors appeared more sensitive to 
high-LET 56Fe than low-LET 137Cs gamma. 
To begin to assess the contribution of oxidative stress after in vitro radiation exposure of 
osteoprogenitors, several antioxidants (including SOD with and without polyethylene glycol 
(PEG); SOD with nanoparticles or liposomes; Catalase with and without PEG) were screened by 
addition to the culture media, with SOD (without carrier) showing the most promising results (data 
not shown). Addition of exogenous SOD (200 U/ml) provided twice a day (on day 3 and day 4) 
effectively protected cell growth from irradiation with 137Cs, whereas higher doses of SOD or 
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longer periods of treatment were less effective (data not shown). As shown in figure 7B, addition 
of SOD prevented the inhibition of growth by 137Cs (200 cGy). In contrast, addition of SOD was 
not as sufficient to rescue the cell death incurred after exposure to an equivalent dose of 56Fe (200 
cGy).  
 
Discussion 
 Heavy-ion irradiation during space missions is a risk to the skeletal health of astronauts, 
causing skeletal degeneration and cellular damage in simulations with rodents [7,15,18]. In this 
study, we sought to elucidate the role of radiation type and changes in the oxidative milieu of 
bone marrow related to marrow-derived osteoprogenitor differentiation. We found that low doses 
(below 50 cGy) of either low-LET protons or high-LET 56Fe did not cause observable adverse 
effects on structure and osteoblastogenesis at any endpoint and, further, did not strongly perturb 
antioxidant capacity at 7 days of exposure (Fig 6) nor expression levels of redox-related genes 
(Fig 4, Table 2) at 35 days of exposure. In contrast, only a high dose of 56Fe radiation (200 cGy) 
was sufficient to induce detrimental effects on total antioxidant capacity, bone structure, and 
osteoprogenitor populations of the marrow (Figs 3-6). These changes were associated with 
transient elevations in mRNA levels (Fig 4C-D) of an antioxidant gene (Catalase) and a DNA-
damage/cell cycle arrest marker (Gadd45) during ex vivo osteoblastogenesis, which we interpret 
to indicate likely persistent oxidative stress during the proliferative phase. Interestingly, cultures 
showed a trend towards elevation of osteocalcin (Bglap, Fig 4D), a late marker of differentiation, 
during the proliferative phase, which may indicate that 56Fe exposure accelerated differentiation.  
Body mass and coat color were assessed as general indices of animal health. Body mass 
indicated that animals showed modest and transient decline in response to 56Fe irradiation with 
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200 cGy (Fig 2), consistent with our previous studies [12]. Additionally, 56Fe irradiation at 200 
cGy uniquely caused a shift in coat color from black to gray. We interpret this as a hallmark of 
oxidative stress in the hair follicle [19], and, when coupled with the osteoprogenitor effects, this 
may signal premature aging in a second tissue, in line with the free-radical theory of cellular 
aging [20,21]. 
In rodents, radiation injury to bone between with 56Fe (10-200 cGy, 1 GeV/n) [12] 
manifests as acute cell death of marrow cells and concomitant cancellous bone loss driven by 
osteoclasts [7,17,22]. In this work, we showed that high-dose 56Fe or proton (200 cGy) caused a 
transient reduction in antioxidant capacity in the marrow microenvironment (Fig 6), potentially 
indicative of a depletion of extracellular antioxidant stores with subsequent recovery of the 
extracellular antioxidant defense system [23]. These findings are consistent with our data 
showing the marrow cell response to increase mRNA expression levels of the master antioxidant 
transcription factor, Nrf2, shown previously [8] and with effects also evident in a cell line at even 
higher doses [14]. Our group showed that a dietary supplement rich in antioxidants and 
polyphenols (dried plum) prevents bone loss and Nrf2 induction from gamma irradiation in mice 
[24], supportive of the role of oxidative stress in driving acute bone loss. Additionally, in vitro, 
200 cGy 56Fe impairs osteoblastogenesis [12]. Our work extends this high-dose impairment in 
vivo and to 5 weeks and 1 year post-exposure, suggesting an irreversible insult to 
osteoblastogenesis. 
Gene expression analyses during the proliferative phase (Fig 4D) revealed that a high 
dose of 56Fe (200 cGy) increased expression of genes for the cell cycle arrest marker Gadd45 and 
antioxidant Catalase relative to sham. These data are consistent with a G2/M arrest from high-
LET irradiation of mesenchymal stem cells [13], a pre-osteoblast cell line [25], and many other 
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cell types [26]. Interestingly, these two genes are targets of Foxo transcription factors [27-29]. 
Nrf2, Foxos, and p21 are critical to the antioxidant response element [30]. Oxidative stress 
activates Foxo transcription factors [31] and interferes with Wnt signaling [9,32-34]. Hence, our 
data suggest Foxo activation may play a role in 56Fe irradiation, decreasing osteoprogenitor cell 
proliferation and, ultimately, mineralization levels.  
During the mineralization phase (Fig 4A-B), 56Fe irradiation (200 cGy) tended to reduce 
nodule formation and alkaline phosphatase gene expression, suggesting a reduction in early 
markers of early-stage osteoblast differentiation and fewer cells contributing to nodule 
formation, consistent with in vitro evidence for high-dose effects [14]. Taken together with gene 
expression data, these findings suggest that irradiation induced persistent oxidative stress that 
impaired colony formation via reduced proliferation (e.g., delayed or halted cell division) leading 
to lower extent of mineralization. Higher doses of gamma irradiation (> 500 cGy) are required to 
recapitulate the impairment of osteoblastogenesis [35,36] – changes also associated with 
oxidative damage [37]. Taking these findings into consideration, the sequelae of a high-dose of 
heavy-ion irradiation is likely impaired osteoblastogenesis which may be attributable to 
persistent oxidative stress. 
For evaluating structural responses, we analyzed cancellous regions in the tibia (Fig 3) 
and the cortical midshaft of the femur (Table 1) at two time points for parameters indicative of 
structural integrity. At 5-weeks after irradiation, exposure to high-LET 56Fe irradiation at or 
above 50 cGy caused decrements in fractional bone volume and trabecular number and increases 
in trabecular spacing (Fig 3), indicating significant deterioration of cancellous microarchitecture, 
consistent with previous findings [15,17,38]. The magnitude of the changes caused by protons or 
56Fe were similar, although the effect of protons at 50 cGy on BV/TV was not statistically 
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significant (p = 0.12). Thus, these findings indicate that the threshold for a persistent, 56Fe 
radiation-induced response lies between 10 and 50 cGy—doses relevant to exploration missions 
[39]. Overall, we show that a high dose of radiation was able to induce persistent decrements in 
cancellous bone, regardless of radiation type (Fig 3). Others have shown that these changes 
persist to 4 months post-exposure [17]. In this study, the structural decrement affected by 56Fe 
(200 cGy) was resolved one year after exposure due to the expected age-related decline in sham-
control animals changes over time (Table 1), likely the product of age-induced elevations of 
osteoclasts overtaking waning bone formation by osteoblasts [40]. These data are consistent with 
our previous findings from growing, female mice after exposure to low-LET gamma radiation 
[41]. Although others have shown cortical changes following irradiation with either low-LET 
gamma at high doses (500 cGy) [42] or high-LET 56Fe at 50 cGy [43], no irradiation-induced 
cortical responses at 1-year post exposure were evident in this study, or in other experiments we 
have performed in the past (data not shown). Thus, the influence of ionizing radiation at 200 cGy 
or below appears to be restricted to the more metabolically-active cancellous tissue.  
In vitro irradiation studies were conducted to further assess the role of oxidative stress in 
radiation damage to osteoprogenitors. Our approach was to test antioxidants and their capacity to 
rescue radiation effects to provide insight into the different mechanisms between low-LET 
radiation and high-LET radiation [44]. Although similar doses of low-LET radiation is generally 
less deleterious than high-LET radiation, the mechanisms for radiation damage to primary, 
marrow-derived osteoprogenitors in the context of oxidative stress are not fully elucidated [45-
47]. Comparing the effects of low-LET radiation (137Cs) and high-LET radiation (56Fe), we found 
high-LET irradiation was more damaging with respect to growth of the cell population, as assessed 
by a surrogate assay (changes in DNA content over time). Furthermore, exogenous SOD 
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effectively protected osteoprogenitors from low-LET radiation damage, but only minimally from 
56Fe at 100 cGy, and not at all from 56Fe at 200 cGy. Taken together, these findings indicate excess 
extracellular reactive oxygen species (ROS) inhibited growth, and that oxidative stress is possibly 
the main mechanism involved in low-LET radiodamage to osteoprogenitors; in contrast, high-LET 
species likely affect the cells via additional detrimental mechanisms, such as double-strand DNA 
breaks.  
Although others [48,49] have shown beneficial effects of varous antioxidants to confer 
radioprotection for various osteoblast cell lines, we show here a direct comparison of antioxidant 
treatment with different radiation species when added to primary, marrow-derived 
osteoprogenitors. Interestingly, adding SOD at higher doses or for longer periods was not 
advantageous, emphasizing the importance of carefully titrating radical scavengers such as SOD, 
possibly to maintain endogenous ROS-dependent signalling.  
In sum, we showed the ability of the antioxidant superoxide dismutase (SOD) to mitigate 
the adverse effects of in vitro irradiation with gamma rays (used for the low-LET radiation), but 
not to an equivalent dose of high-LET 56Fe. Our results strengthen the potential application of 
SOD as a countermeasure for low-LET irradiation-induced damage to marrrow stem cells and 
osteoprogenitors.  
 Inherent limitations of these experiments with respect to radiation exposures include: 1) 
exposures were delivered at high dose-rate and fluence in a matter of minutes, whereas in space, 
the same dose is delivered at a lower rate, and 2) space exposures are mixed doses, rather than a 
single species (e.g. SPE can deliver 100-200 cGy over 2 days and GCR over several years). In 
addition, with respect to relevance to spaceflight, these experiments were performed in mice that 
were normally ambulatory, thus not subjected to musculoskeletal disuse and fluid shifts which 
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are induced by microgravity; groundbased models for spaceflight have shown that unloading can 
influence radiosensitivity [12,18,50,51]. 
In summary, our findings indicate that although low doses of radiation do not show  
lasting effects on skeletal health, high dose of high-LET 56Fe, impairs osteoblast growth and 
maturation by adversely affecting growth of osteoprogenitors. There were few, select changes in 
steady-state expression of redox-related genes during osteoblastogenesis ex vivo after total body 
irradiation with 56Fe (but not protons), with some indication of altered expression of select 
genes during the proliferative phase. Furthermore, scavenging ROS with antioxidants such as 
SOD mitigated adverse effects of in vitro irradition with protons (200 cGy), but failed to protect 
from irradiation with an equivalent dose of heavy ions. Together, our findings indicate that 
irradiation has a persistent effect to impair bone formation by adversely affecting growth, but 
not differentiation, of osteoprogenitors. 
 
Materials and Methods  
Animals 
Male C57BL/6J mice (Jackson Laboratories) were individually housed under standard 
conditions and provided food (LabDiet 5001, Purina) and water ad libitum as described by [8]. 
As a general measure of animal health, we measured body mass weekly for the duration of the 
study. Additionally, we blindly scored coat color as black or gray at the one-year post-irradiation 
endpoint. Animals were euthanized by cardiac puncture while under isoflurane overdose 
followed by cervical dislocation. The Institutional Animal Care and Use Committees for NASA 
Ames Research Center and Brookhaven National Laboratory approved all procedures. 
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In vivo Experiment Design and Radiation Exposure 
Two experiments using mice were conducted to assess the effect of radiation type on 
skeletal antioxidant response, osteoblastogenesis, and bone structure. In the first experiment 
(Figure 1A), conscious 16-wk old, male, C57BL6/J mice were exposed to low-LET protons (150 
MeV/n, LET ~ 0.52 keV/µm) or high-LET 56Fe ions (600 MeV/n, LET ~ 175 keV/µm) at 5, 10, 
50, or 200 cGy at NASA’s Space Radiation Lab at Brookhaven National Lab (Upton, NY). 
Between 7-9 days after irradiation, mice were shipped overnight from Brookhaven to NASA 
Ames Research Center, Moffett Field, CA. Select groups of mice were euthanized and tissues 
harvested after 35-38 days for 56Fe, 36-39 days for proton, or 36-38 days for the sham (these 
three groups are deemed 5 weeks post-irradiation and had n = 8 per group) and late (358 or 360 
days, here deemed 1 year post-irradiation and had n = 13 per group) for ex vivo osteoprogenitor 
culture of marrow cells. Tibiae or femora were collected for cancellous microarchitecture 
assessment with microcomputed tomography. For the 5-week endpoint, osteoblast cultures (n = 
6-7 mice / group) were analyzed by real-time qPCR (n = 4 mice / group, see below for details), 
total DNA quantification, and alkaline phosphatase activity during the proliferative phase (7 days 
after plating) or the mineralization phase (19-21 days after plating) stages of osteoblast 
differentiation. At the termination of cultures, mineralized nodules were imaged and analyzed for 
percent surface area at the end of the culture period. For the 1-year endpoint, osteoblast cultures 
(n = 6 / group) were analyzed for colony number during the proliferative phase (8 days after 
plating) or for mineralized nodule area during the mineralization phase (28 days after plating) of 
osteoblast differentiation. 
In the second experiment (Figure 1B), we aimed to determine the effects of total-body 
irradiation on the antioxidant capacity of the extracellular fluid surrounding the marrow cells 
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[52]. To evaluate ion effects, conscious 16-wk old, male, C57BL6/J mice mice were exposed to 
10 or 200 cGy of low-LET protons (n = 6-8 per group) or 5 or 200 cGy of high-LET 56Fe ions 
(n=8 per group) as described above, or were sham irradiated (n = 13 per group). Mice were 
euthanized and tissues harvested at 1 or 7 days after exposure, at which point tibial marrow was 
processed for extracellular fluid collection and quantification of total antioxidant capacity, 
described in more detail below. 
 
In vitro Experiment Design and Radiation Exposure 
Osteoprogenitors were grown in vitro from the bone marrow of 16-week old, male C57Bl/6 
mice as previously described [12]. Cells were irradiated 3 days after plating (day 3) with either 
gamma (137Cs, sham or 10 – 500 cGy, JL Shepherd Mark I) or 56Fe (sham or 50 – 200 cGy, NSRL), 
and then grown until day 10. Cell behavior was assessed by measuring changes in DNA content 
between day 3 and day 10 (as a surrogate for cell growth) with the Cyquant assay as previously 
described [12]. For the SOD experiment, multiple doses were tested in preliminary experiments 
(100-600 U/ml of SOD or vehicle, for 2 or 3 days of treatment at different times). The protocol 
selected for more extensive dose-response experiments entailed the addition of SOD (200 U/ml), 
or vehicle (-MEM) 2 hours before irradiation (day 3), twice a day, through the 4th day after 
exposure to radiation. Experiments were repeated 2-3 times. Data were normalized to the sham-
control.  
 
Total Antioxidant Capacity 
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We measured the antioxidant capacity of the extracellular fluid of the marrow (i.e., the 
marrow plasma) with a colorimetric assay based on the reduction potential of Cu2+ to Cu1+ as 
compared to Trolox equivalent standards (Oxford Biomedical, Oxford, MI). In brief, we isolated 
marrow ex vivo, using 150 µL of sterile saline to flush the marrow from the tibial diaphysis, as 
described previously [52]. The solution was centrifuged and supernatant preserved as the 
extracellular fluid at -80˚C for further assessment. The BCA assay assessed the protein 
concentration of the extracellular fluid against albumin standards, which enabled normalization 
of the antioxidant capacity by the protein concentration to account for changes in protein levels 
with treatment [52]. 
 
Bone Microarchitecture and Geometry 
Bone volume and microarchitecture of the proximal tibial metaphysis were quantified by 
microcomputed tomography (6.7 µm pixel size, 3500 ms integration time, 50 kV, Skyscan 1174; 
Bruker microCT) similar to [8]. Briefly, a 1.0-mm thick region located 0.24 mm distal to the 
proximal growth plate of the tibia was selected and semi-autonomously contoured to include 
cancellous tissue. We assessed changes in cancellous bone using the three-dimensional bone 
volume to total volume fraction (BV/TV, %), trabecular thickness (Tb.Th, mm), trabecular 
number (Tb.N, 1/mm), trabecular thickness (Tb.Th, mm), and trabecular separation (Tb.Sp, mm).  
We assessed changes in cortical bone at midshaft using bone volume and cortical thickness. All 
analyses follow conventional guidelines [53]. 
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Ex vivo Osteoblastogenic Assays and qRT-PCR Analyses 
For osteoblastogenic culture, femur marrow was flushed using saline and treated with 
lysis buffer specific for red blood cells (Sigma-Aldrich, St. Louis, MO), centrifuged for ten 
minutes at 1000 x g, and supernatant removed. Cells were then re-suspended and plated at 3.0 x 
105 cells/cm2 in 6-well plates. Osteoblastogenic growth medium (alpha minimum essential 
medium with 15% FBS (Gibco, Gaithersburg, MD), 1x anti-biotic/mycotic, 50 µg/ml ascorbic 
acid, 10 mM beta-glycerophosphate) was replenished every 2-3 days.  
For qPCR analyses (n=4/group), cells were collected in a solution of 1% beta-
mercapthoethanol in RLT Buffer (Qiagen, Valencia, CA) and stored at -80˚C until RNA 
isolation via RNeasy minikit (Qiagen). RNA quantity and purity was measured using a nanodrop 
spectrophotometer (Thermoscientific Nanodrop 2000) while RNA quality was assessed using a 
0.8% non-denaturing gel. A RT2PCR custom array (PAMM-999A-1, SYBR probes, Qiagen) was 
processed with an Applied Biosystems 7500 cycler to generate gene expression data. The ΔΔCt 
method was used to analyze the raw data. Cycle values above 35 were defined as non-detectable. 
Statistical analyses were performed on log2-transformed data. Fifteen representative genes were 
analyzed to assess osteoblast differentiation, proliferation, oxidative metabolism, or apoptosis, 
see Table 3. All genes were normalized to housekeeping gene Hprt. Technical issues forced the 
loss of one specimen from the 56Fe, 200 cGy group during the proliferative phase and the loss of 
all four specimens in the proton, 10 cGy group from mineralization phase. 
For ALP and DNA analyses, cells were collected in a solution of Tris buffer containing 
Triton-X and MgCl2 and stored at -80C. Quantification of ALP enzymatic activity and total 
DNA content was performed using Alkaline Phosphatase Activity Colorimetric Assay 
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(Biovision, Mountain View, CA) and CyQuant Cell Proliferation Assay Kit 
(ThermoFisherScientific), respectively. 
Colony counts early in culture assessed the successful adherence and proliferation of 
colony forming units. Parameters defining a colony included having distinct region of radial 
colony growth and having more than 30 cells with a majority of cells having of morphological 
homogeneity. 
To quantify densely mineralizing area (i.e. the nodule area), we harvested cultures in the 
differentiation phase. First, we washed cultures with saline and scanned the plates at 300 dpi 
resolution. We quantified the percentage of well area having mineralizing nodules with Image J, 
using a custom algorithm to threshold the grayscale image. 
 
Statistics 
We report parametric data with mean and standard deviation (SD). To determine 
significant differences compared with age-matched sham-irradiated controls, a 1-way analysis of 
variance was used followed by Dunnett’s post-hoc test.  For non-parametric data (i. e., nodule 
area data, as values near zero display skew), we report the median with interquartile range. To 
determine significant differences compared with age-matched, sham-irradiated controls, we used 
a Kruskal-Wallis test with Steel post-hoc test. We assessed temporal (within subjects) treatment 
(between subjects) effects in body mass, and their interaction (i.e., time*treatment), using 
Repeated Measures ANOVA and Wilks’ Lamda test. Throughout, a p-value ≤ 0.05 was accepted 
as significant. We performed all analyses performed using JMP 13 (SAS). 
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Tables 
Table 1: Cancellous microarchitecture of the proximal tibial metaphysis 1 year after 56Fe 
irradiation. 
  Sham 10 cGy 50 cGy 200 cGy 
Percent Bone Volume (%) 9.7 ± 3.1 8.7 ± 2.4 8.2 ± 2.9 7.2 ± 1.5 
Trabecular Thickness (μm) 59.3 ± 5.3 58.2 ± 3.2 57.7 ± 2.9 57.1 ± 2.7 
Trabecular Separation (μm) 228.8 ± 23.3 245.0 ± 41.8 240.1 ± 30.2 248.5 ± 18.4 
Trabecular Number (1/mm) 1.62 ± 0.36 1.49 ± 0.35 1.42 ± 0.48 1.26 ± 0.23 
 
 
Table 2. List of genes quantified from ex vivo culture which did not show significant changes in 
expression levels. Cells were isolated and cultured 5 weeks post-irradiation and analyzed at 
proliferative and terminally differentiated stages in growth.  
Proliferative Stage     Terminal Differentiation 
Caspase 3 Foxo1 p21 Runx2 Caspase 3 Gadd45 p53 
Cdk2 GPX p53   Catalase iNos PCNA 
CuZnSOD MnSOD PCNA   Cdk2 MnSOD   
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Table 3: SYBR-based custom array to query changes in expression levels of key genes. 
 
Gene Name Accession No. Official Name Process 
Runx2 NM_009820 Runt Related Transcription Factor 2 Differentiation 
Bglap NM_ 007541 Bone gamma carboxyglutamate protein (osteocalcin) Differentiation 
Alpl NM_007431 Alkaline Phosphatase Ligand Differentiation 
Pcna NM_011045 Proliferating Cell Nuclear Antigen Proliferation 
Cdk2 NM_016756 Cyclin-dependent Kinase 2 Proliferation 
p21 NM_007669 Cyclin-dependent Kinase Inhibitor 1 Proliferation 
p53 NM_011640 Transformation-related protein 53 Proliferation 
Cat NM_009804 Catalase Oxidative Metabolism 
Gpx1 NM_008160 Glutathione Peroxidase Oxidative Metabolism 
MnSod NM_013671 Superoxide Dismutase 2, Mitochondrial Oxidative Metabolism 
CuZnSod NM_011434 Superoxide Dismutase Oxidative Metabolism 
iNos [Nos2] NM_010927 Nitric Oxide Synthase 2, Inducible Oxidative Metabolism 
Foxo1 NM_019739 Forkhead Box Oxidative Metabolism 
Gadd45a NM_007836 Growth Arrest and DNA Damage Oxidative Metabolism 
Caspase 3 NM_009810 Caspase 3 Apoptosis 
Hprt NM_013556 Hypoxanthine-guanine phosphoribosyltransferase Housekeeping 
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Figure Legends 
Figure 1: Total Body Irradiation (TBI) experiment designs. (A) Experiments to determine whether 
TBI alters antioxidant gene expression in osteoblasts, osteoblastogenesis, and the structure of 
cancellous bone in an ion-dependent fashion at 5 weeks after proton or 56Fe exposure and to 
determine the osteoblastogenic and structural sequelae of 56Fe irradiation 1 year after exposure. At 
each endpoint, marrow cells were cultured for osteoblastogenesis. At 5 weeks post-irradiation, 
osteoblastogenic cultures were halted during the proliferative phase and differentiation phase for 
gene expression assessment. (B) Experiment to determine the acute effect of proton or 56Fe 
irradiation on the antioxidant status of the bone marrow extracellular fluid (ECF). Mice were 
irradiated and euthanized either 1 or 7 days after exposure. Marrow was collected and cells 
removed through centrifugation. The supernatant, defined as the extracellular fluid (ECF), was 
assessed for total antioxidant capacity.  
 
Figure 2: Longitudinal body mass measurements of 56Fe-irradiated mice up to 1 year post-
exposure (mice from Fig 1A). Mice were irradiated on day 0 and shipping took place between days 
6 and 8. Data are mean ± SD with n=13 per group. 
 
Figure 3: Dose response of cancellous bone microarchitecture following proton or 56Fe irradiation 
at 5 weeks after exposure (mice from Fig 1A). Microarchitecture was assessed using 
microcomputed tomography and the parameters of (A) bone volume / total volume (BV/TV, %) 
and (B) trabecular number (Tb.N, 1/mm). Data are mean ± SD, with n = 8 / group. * denotes p ≤ 
0.05 vs. age-matched sham control. 
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Figure 4: Differentiation and proliferation responses of osteoprogenitors cultured from bone 
marrow of mice that received proton or 56Fe irradiation (5 weeks post-irradiation from mice in Fig 
1A). (A) Nodule area of cultures from animals irradiated with 200 cGy proton or 56Fe compared 
to sham control. Data are summarized by median and interquartile range with n = 5-6/group. (B) 
Grayscale (top row) and binarized (bottom row) images of representative wells (i.e., near the group 
median), showing nodules during the mineralization phase for 200 cGy proton or iron or sham. 
Gene expression assessed during (C) terminal differentiation or (D) proliferation for markers of 
differentiation, damage response, cell cycle, and redox response in cells cultured from the marrow 
of previously irradiated mice. Data are mean ± SD of Log2 (Fold Change) transformed values 
relative to the endogenous gene HPRT and normalized to the sham control (i.e., Ct). The 
dashed line at 1.0 indicates the sham control level. n = 5-6/group, * denotes p ≤ 0.05 vs. sham-
control. 
 
Figure 5: Persistent effects of 56Fe (200 cGy) TBI on osteoblastogenesis at 1 year post-exposure 
(mice from Fig 1A). Marrow was cultured in osteoblastogenic conditions. We quantified (A) 
colony number on day 8 in vitro and (B) nodule area on day 28 in vitro. Data are summarized by 
median and interquartile range, with n = 5-6/group. 
 
Figure 6: Irradiation perturbation of the marrow oxidative milieu, assessed by the antioxidant 
capacity of the extracellular fluid (ECF), in mice at 1 and 7 days post exposure (following timeline 
in Fig 1B). Mice were irradiated with 56Fe at 5 or 200 cGy or protons at 10 or 200 cGy. Data are 
mean ± SD. *p ≤ 0.05 versus sham control. 
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Figure 7: In vitro irradiation effects on osteoblastogenesis. (A) Dose response curve of 
osteoprogenitor growth after exposure to radiation using low-LET 137Cs or high-
LET 56Fe. (B) Addition of the antioxidant SOD and its prevention of the irradiation-induced 
decrement in cell growth. Data are shown normalized to the sham control (which is depicted by 
the dashed line at 1.0), expressed as mean ± SD. * denotes p ≤ 0.05 versus the sham-irradiated 
control. 
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